308 related articles for article (PubMed ID: 1911545)
21. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.
Ozden S; Cochet M; Mikol J; Teixeira A; Gessain A; Pique C
J Virol; 2004 Oct; 78(19):10320-7. PubMed ID: 15367598
[TBL] [Abstract][Full Text] [Related]
22. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
[TBL] [Abstract][Full Text] [Related]
23. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
Daenke S; Kermode AG; Hall SE; Taylor G; Weber J; Nightingale S; Bangham CR
Virology; 1996 Mar; 217(1):139-46. PubMed ID: 8599198
[TBL] [Abstract][Full Text] [Related]
24. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
25. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
[TBL] [Abstract][Full Text] [Related]
26. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
27. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
28. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
[TBL] [Abstract][Full Text] [Related]
29. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
30. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.
Parker CE; Nightingale S; Taylor GP; Weber J; Bangham CR
J Virol; 1994 May; 68(5):2860-8. PubMed ID: 7512153
[TBL] [Abstract][Full Text] [Related]
31. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy.
Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; Rudge P; Matutes E; Bangham CR; Weber JN
J Virol; 1999 Dec; 73(12):10289-95. PubMed ID: 10559346
[TBL] [Abstract][Full Text] [Related]
32. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
[TBL] [Abstract][Full Text] [Related]
33. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
34. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
[TBL] [Abstract][Full Text] [Related]
35. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
[TBL] [Abstract][Full Text] [Related]
37. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
[TBL] [Abstract][Full Text] [Related]
38. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
Gómez-Acevedo H; Li MY; Jacobson S
Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic and suppressor activities in patients with HTLV-I-associated myelopathy.
Usuku K; Nishizawa M; Osame M; Tabira T
J Neuroimmunol; 1991 Sep; 33(3):199-205. PubMed ID: 1831463
[TBL] [Abstract][Full Text] [Related]
40. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.
Kubota R; Soldan SS; Martin R; Jacobson S
J Neurovirol; 2002 Feb; 8(1):53-7. PubMed ID: 11847592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
